Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia
Sandra Palus, Stephan von Haehling, V FLACH, et al.
International Journal of Cardiology (2013) Vol. 168, Iss. 4, pp. 3412-3418
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Cardiac cachexia: hic et nunc
Goran Loncar, Jochen Springer, Markus S. Anker, et al.
Journal of Cachexia Sarcopenia and Muscle (2016) Vol. 7, Iss. 3, pp. 246-260
Open Access | Times Cited: 119
The pathogenesis and treatment of cardiac atrophy in cancer cachexia
Kate T. Murphy
AJP Heart and Circulatory Physiology (2015) Vol. 310, Iss. 4, pp. H466-H477
Open Access | Times Cited: 107
Cardiotoxicity: Cisplatin and long-term cancer survivors
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 175, Iss. 1, pp. 201-202
Closed Access | Times Cited: 99
Cardiac muscle wasting in individuals with cancer cachexia
Anush Barkhudaryan, Nadja Scherbakov, Jochen Springer, et al.
ESC Heart Failure (2017) Vol. 4, Iss. 4, pp. 458-467
Open Access | Times Cited: 95
Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity
Yassine Belloum, Françoise Rannou‐Bekono, F. Favier
Oncology Reports (2017) Vol. 37, Iss. 5, pp. 2543-2552
Open Access | Times Cited: 81
Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
Seyyed Mohammad Reza Kazemi‐Bajestani, Harald Becher, Konrad Fassbender, et al.
Journal of Cachexia Sarcopenia and Muscle (2014) Vol. 5, Iss. 2, pp. 95-104
Open Access | Times Cited: 69
Molecular and cell-based therapies for muscle degenerations: a road under construction
Emanuele Berardi, Daniela Annibali, Marco Cassano, et al.
Frontiers in Physiology (2014) Vol. 5
Open Access | Times Cited: 67
Therapeutic strategies against cancer cachexia
Josep M. Argilés, Francisco J. López‐Soriano, Britta Stemmler, et al.
European Journal of Translational Myology (2019) Vol. 29, Iss. 1
Open Access | Times Cited: 57
Novel targeted therapies for cancer cachexia
Josep M. Argilés, Francisco J. López‐Soriano, Britta Stemmler, et al.
Biochemical Journal (2017) Vol. 474, Iss. 16, pp. 2663-2678
Open Access | Times Cited: 61
Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
Vincenzo Musolino, Sandra Palus, Anika Tschirner, et al.
Journal of Cachexia Sarcopenia and Muscle (2016) Vol. 7, Iss. 5, pp. 555-566
Open Access | Times Cited: 56
Fat Wasting Is Damaging: Role of Adipose Tissue in Cancer-Associated Cachexia
Xiaoting Sun, Xiaogang Feng, Xiaojing Wu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 47
Activated ROCK/Akt/eNOS and ET-1/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin
Radwa N. Muhammad, Nada A. Sallam, Hanan Salah El-Abhar
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release
Lin Zhou, Tong Zhang, Wei Shao, et al.
Skeletal Muscle (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Cardiotoxicity: Anthracyclines and long term cancer survivors
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1326-1328
Closed Access | Times Cited: 50
HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1082-1085
Closed Access | Times Cited: 44
Macrophages protect against loss of adipose tissue during cancer cachexia
Merve Erdem, Diana Möckel, Sandra Jumpertz, et al.
Journal of Cachexia Sarcopenia and Muscle (2019) Vol. 10, Iss. 5, pp. 1128-1142
Open Access | Times Cited: 39
A challenge in cardiology: The oncosurgery
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 174, Iss. 2, pp. 411-412
Closed Access | Times Cited: 41
M3 muscarinic acetylcholine receptor in cardiology and oncology
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 177, Iss. 2, pp. 646-649
Closed Access | Times Cited: 38
ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugs
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1301-1303
Closed Access | Times Cited: 35
Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
Annika Ritz, Eberhard Lurz, Michael Berger
Cells (2022) Vol. 11, Iss. 8, pp. 1278-1278
Open Access | Times Cited: 19
Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy
Ruoxin Fang, Ling Yan, Zhengkai Liao
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 176, Iss. 3, pp. 1306-1308
Closed Access | Times Cited: 34
Ebola: Is there a hope from treatment with cardiovascular drugs?
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 177, Iss. 2, pp. 524-526
Closed Access | Times Cited: 33
Cardiotoxicity: Trastuzumab and cancer survivors
Salvatore Patanè
International Journal of Cardiology (2014) Vol. 177, Iss. 2, pp. 554-556
Closed Access | Times Cited: 32
Exercise Training as Therapy for Cancer-Induced Cardiac Cachexia
J.M.M. Antunes, Rita Ferreira, Daniel Moreira‐Gonçalves
Trends in Molecular Medicine (2018) Vol. 24, Iss. 8, pp. 709-727
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top